Format

Send to

Choose Destination
See comment in PubMed Commons below
Biomed Pharmacother. 2014 Mar;68(2):163-9. doi: 10.1016/j.biopha.2013.12.001. Epub 2013 Dec 24.

miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.

Author information

1
Department of Gynecology, Qilu Hospital of Shandong University, 250012 Jinan, China; Department of Gynecology, Yantai Yuhuangding Hospital of Qingdao University Medical College, 264000 Yantai, China.
2
Department of Gynecology, Yantai Yuhuangding Hospital of Qingdao University Medical College, 264000 Yantai, China.
3
Department of Gynecology, Qilu Hospital of Shandong University, 250012 Jinan, China. Electronic address: xingsheng6615@163.com.

Abstract

MiRNAs have been reported as important regulators in normal physiological processes, human cancer, and even their roles as therapeutic targets have been proposed. In epithelial ovarian cancer (EOC), the expression of miRNAs is reported to remarkably deregulate, showing that miRNAs are involved in the initiation and progression of this disease. In this study, we found that miR-99a was obviously decreased in EOC tissues, serums and cell lines SKOV-3. Importantly, fibroblast growth factor receptor 3 (FGFR3), predicted to be one target gene of miR-99a using computational algorithms, was higher in expression in EOC cells. Subsequently, FGFR3 was proved to be direct target of miR-99a by dual luciferase assay. Furthermore, overexpression of miR-99a dramatically suppressed expression level of FGFR3 at both mRNA and protein levels, proving FGFR3 to be inversely correlated with miR-99a. Finally, overexpression of miR-99a could significantly inhibit EOC cell proliferation in vitro by decreasing the expression of FGFR3 which also reduced the EOC cell growth after siRNA knockdown. Conclusively, miR-99a expression was remarkably downregulated in serums, tissues and cell and suppresses EOC cell proliferation by targeting FGFR3, suggesting miR-99a as a prospective prognosis marker and potential tumor suppressor for EOC therapeutics.

KEYWORDS:

EOC; FGFR(3); Ovarian cancer; Proliferation; miR-99a

PMID:
24456664
DOI:
10.1016/j.biopha.2013.12.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center